Efficacy of Nivolumab in a Patient with Metastatic Renal Cell Carcinoma and End-Stage Renal Disease on Dialysis: Case Report and Literature Review

<div>Axial contrast-enhanced corresponding CT scan images after 12 weeks of nivolumab treatment showing a partial response with reduction in size of multiple bilateral lung metastases (white arrows).</div>

Case Reports in Immunology

fig2

Figure 2

Figure 2: Efficacy of Nivolumab in a Patient with Metastatic Renal Cell Carcinoma and End-Stage Renal Disease on Dialysis: Case Report and Literature Review 

Figure 2 | Efficacy of Nivolumab in a Patient with Metastatic Renal Cell Carcinoma and End-Stage Renal Disease on Dialysis: Case Report and Literature Review 